Cargando…
Apixaban returned to CVS Caremark formulary after outcry
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326280/ https://www.ncbi.nlm.nih.gov/pubmed/35910941 http://dx.doi.org/10.1002/rth2.12774 |
| _version_ | 1784757248352845824 |
|---|---|
| author | Waldron, Beth |
| author_facet | Waldron, Beth |
| author_sort | Waldron, Beth |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9326280 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93262802022-07-30 Apixaban returned to CVS Caremark formulary after outcry Waldron, Beth Res Pract Thromb Haemost Letters to the Editor John Wiley and Sons Inc. 2022-07-26 /pmc/articles/PMC9326280/ /pubmed/35910941 http://dx.doi.org/10.1002/rth2.12774 Text en © 2022 The Author. Research and Practice in Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis (ISTH). https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Waldron, Beth Apixaban returned to CVS Caremark formulary after outcry |
| title | Apixaban returned to CVS Caremark formulary after outcry |
| title_full | Apixaban returned to CVS Caremark formulary after outcry |
| title_fullStr | Apixaban returned to CVS Caremark formulary after outcry |
| title_full_unstemmed | Apixaban returned to CVS Caremark formulary after outcry |
| title_short | Apixaban returned to CVS Caremark formulary after outcry |
| title_sort | apixaban returned to cvs caremark formulary after outcry |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326280/ https://www.ncbi.nlm.nih.gov/pubmed/35910941 http://dx.doi.org/10.1002/rth2.12774 |
| work_keys_str_mv | AT waldronbeth apixabanreturnedtocvscaremarkformularyafteroutcry |